
The boring box is getting bigger
DocuSign is trying to escape the “just e-signatures” label, and Wall Street is starting to notice. After the company’s fiscal second quarter, analysts pointed to faster growth in Intelligent Agreement Management, better retention, and a profitability profile that came in stronger than expected.
The AI angle is doing the heavy lifting
Citizens’ Patrick Walravens kept a Market Outperform rating and slapped on an $86 price target. His thesis: DocuSign is turning into the “agreement layer” for enterprises, with IAM annual recurring revenue hitting about $529 million and already making up 15.1% of total ARR.
That matters because the more DocuSign sells software beyond basic signatures, the less it looks like a one-trick pony. Walravens thinks IAM could top $650 million by fiscal 2027. Translation: the AI story isn’t just frosting — it might be the cake.
The stock still has a valuation problem
RBC Capital Markets was more of a “nice progress, but let’s not get carried away” situation. Analyst Rishi Jaluria kept a Sector Perform rating, raised his price target to $70 from $55, and said the quarter showed real traction in retention, larger deals, and third-party AI integrations.
But there’s a catch: RBC thinks the shares already bake in a lot of that good news. In other words, DocuSign is improving, but the market may have already RSVP’d to the party.
Why investors should care
The key tension here is simple:
- Growth is reaccelerating in the new AI-focused business.
- Profitability is better than feared.
- But the stock isn’t exactly cheap, so upside may depend on DocuSign proving that IAM can become a much bigger engine.
Big picture: DocuSign is trying to become more than the app you use to sign a lease at 11:47 p.m. Wall Street likes the makeover — it just wants to know whether the new outfit is worth the price tag.